Elevation of Fasting GLP-1 Levels in Child and Adolescent Obesity: Friend or Foe?
Glucagon-like peptide-1 (GLP-1) receptor agonists have been gaining much attention as a therapeutic approach to type 2 diabetes and obesity. Stinson et al recently reported that fasting GLP-1 is higher in children and adolescents with overweight/obesity and that it associates with cardiometabolic ri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372656/ https://www.ncbi.nlm.nih.gov/pubmed/33950185 http://dx.doi.org/10.1210/clinem/dgab301 |